HOME >> BIOLOGY >> NEWS
Hopkins Study Shows Brain Damage Evidence In "Ecstasy" Users

"...people who use (it) unwittingly put themselves at risk"

The common street drug "ecstasy" causes brain damage in people, according to a new Johns Hopkins study. In a report in The Lancet released this week, Hopkins scientists show that the drug -- known chemically as MDMA -- damages specific nerves in the brain that release serotonin, the nerve transmitter thought to play a role in regulating mood, memory, pain perception, sleep, appetite and sexual activity.

"We had long suspected MDMA was dangerous, based on our earlier studies in primates that showed nerve damage at doses similar to those taken by recreational drug users," says neurologist George Ricaurte, M.D., Ph.D., who led the research team. Additional studies by the team examined drug users' spinal fluid for levels of a serotonin by product; reduced amounts strongly suggested brain damage in humans.

"But this is the first time we've been able to examine the actual serotonin-producing nerve cells directly in the brain," Ricaurte says. Using a nerve-specific technique that took more than five years to develop, the scientists took PET scans of 14 men and women who reported heavy use of ecstasy. With a radio-labeled probe, the team targeted molecules -- serotonin transporters -- that normally reabsorb serotonin into nerve cells after it has done its job.

Like certain antidepressants, MDMA also attaches to serotonin transporters. The transporters lie embedded in the membranes of nerve cells, at the tips of fingerlike extensions called axons.

In the study, the PET scans showed MDMA users had far fewer serotonin transporters than controls who didn't use the drug. Also, the greater the use of MDMA -- some of the subjects had used it 200 or more times -- the greater the loss. "These losses are significant, and, along with our early studies in animals, suggest that nerve cells are damaged," says Ricaurte. Whether or not the cells a
'"/>

Contact: Marjorie Centofanti
mcentofanti@jhmi.edu
410-955-8725
Johns Hopkins Medical Institutions
30-Oct-1998


Page: 1 2

Related biology news :

1. Hopkins scientists use blood proteins to detect ovarian cancer
2. Hopkins to found first center for comprehensive study of epigenetics
3. Hopkins scientists overcome main obstacle to making tons of short, drug-like proteins
4. Hopkins Marine Station honored by the American Society for Microbiology
5. Johns Hopkins gene hunters pinpoint new cancer gene target
6. Hopkins researchers identify transplantation antigens among Sioux Indians
7. Hopkins researchers discover how nitric oxide prevents blood vessel inflammation
8. Hopkins is first US institution to obtain powerful genotyping system
9. Dr. Robot tested at Hopkins
10. From Hopkins: Children may outgrow peanut allergies
11. OXiGENE announces launch of ophthalmic clinical trial at The Johns Hopkins School of Medicine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. ... of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), ... Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, ...
(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, a registered ... common and aggressive adult brain cancer—announced today the appointments of its first Senior ... with supporting the organization’s initiatives and overall vision. , "Senior Fellows are more ...
(Date:6/25/2020)... ... June 24, 2020 , ... eClinical Solutions LLC ... services that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: KPTI ... patients with severe COVID-19. This is the first study of an XPO1 inhibitor ...
Breaking Biology News(10 mins):
(Date:8/7/2020)... (PRWEB) , ... August 06, 2020 , ... ... DNA vaccine industries, announces it has closed on the purchase of greenfield for ... in Conroe, TX and includes over 21 acres in the initial acquisition, with ...
(Date:7/31/2020)... COLLEGE STATION, Texas (PRWEB) , ... July 29, ... ... pre-qualified cleanroom solutions today announced the launch of its new tagline, “BUILDING FOR ... within the biopharmaceutical industry and around the globe, requiring fast track capacity to ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as ... cover the history of eSource, the reasons it did not take off as quickly ... site source, the industry is moving towards capturing data electronically for clinical trials and ...
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... After research ... The completion of a great surgery is only the beginning of a successful study, ... research community. , Join Brad Gien, Global Head of Surgery from Envigo ...
Breaking Biology Technology:
Cached News: